Evaluation of a mouse model of chronic obstructive pulmonary disease induced by intraperitoneal injections of cigarette smoke extract
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1001-0939.2015.04.010
- Key Word:
- 肺疾病,慢性阻塞性;肺气肿;模型,动物;烟草烟雾提取物;Obstructive pulmonary disease,chronic;Emphysema;Model,animal;Cigarette smoke extract
Abstract： Objective To evaluate a mouse model of chronic obstructive pulmonary disease (COPD) induced by intraperitoneal injections of cigarette smoke extract (CSE),and to study the potential mechanisms.Methods Mice were injected intraperitoneally with CSE at different time points to establish a mouse model of COPD.Mouse lung mechanics parameters were measured,and the total numbers and differentials of cells in bronchoalveolar lavage fluid (BALF) were counted.Pathological changes of lung tissue were observed and mean linear intercept (MLI) and alveolar destructive index (DI) were measured.The expressions of matrix metalloproteinases-12 (MMP12),neutrophil elastase (NE),tissue inhibitor of metalloproteinase-1 (TIMP1),pro-inflammatory cytokines (TNF-α,IL-1β,IL-6),Th1 cytokines (IFN-γ),Th2 cytokines (IL-5,IL-13) and the neutrophil chemokine KC were determined in the lungs of all mice.Results Significant increase of total lung capacity (TLC) [(0.73 ± 0.02),(0.83 ± 0.04),(O.97 ±0.02) ml] was found in the CSE group as compared with the PBS control group [(0.65 ± 0.01),(0.67 ±0.02),(0.71 ±0.04)ml,t=4.109,3.666,5.994,P＜0.01] at day 21,41,61.Lung compliance was higher in the CSE group [(0.041 ±0.002) ml/cmH2O (1 cmH2O =0.098 kPa),(0.039 ±0.001) ml/cmH2O] than the PBS control group [(0.030 ± 0.001) ml/cmH2O,(0.032 ± 0.003) ml/cmH2O,t =4.788,2.508,P ＜0.05] at day 41,61,but airway resistance in the lungs (R) was lower in the CSE group [(0.959 ±0.016) cmH2O · s · ml-1,(0.976 ±0.020) cmH2O · s · ml-1] than the PBS control group [(1.043±0.022) cmH2O · s · ml-1,(1.085 ±0.043) cmH2O · s · ml-1] (t=2.928,2.321,P＜0.05).The total numbers of BALF cells in the CSE group [(23.83 ±2.63) × 104,(20.67 ± 1.69) × 104,(18.67 ± 1.56) × 104] were increased compared with the PBS control group [(7.33 ± 0.61) × 104,(7.67±0.76) × 104,(6.67 ±0.88) × 104,t =6.119,7.027,6.685,P ＜0.01] at day 21,41,61,predominantly with neutrophils and macrophages.Typical COPD pathological changes of lung tissue were evident,including Inflammatory cell infiltration in the lung parenchyma and increased mean linear intercept (MLI) in the CSE group [(48.0 ± 1.4),(56.1 ± 2.4),(59.3 ± 3.3) μm] as compared with the PBS control group [(40.5 ± 1.2),(43.7 ± 1.2),(43.5 ± 1.2)μm,t =4.015,4.695,4.612,P ＜ 0.01] aswell as increased alveolar destructive index (DI) in the CSE group [(15.2 ± 1.3) ％,(22.4 ± 1.3) ％,(23.8 ± 1.0) ％] as compared with the PBS control group [(11.1 ± 0.9) ％,(10.8 ± 1.0) ％,(12.4 ±0.7)％,t =2.532,7.225,8.471,P ＜ 0.05] at the 3 time points.The expressions of MMP12 and NE increased significantly in the CSE-treated mice.Pro-inflammatory cytokines (TNF-α,IL-1β,L-6),Th1 cytokine IFN-γand KC all increased significantly in the CSE-treated mice as compared with the PBS-control mice.Conclusions A mouse model of COPD was successfully established by repeated intraperitoneal injections of CSE in a shorter period of time.Local inflammation and proteinase/anti-proteinase imbalance as a result of CSE-induced immunological responses may be the underlying mechanisms.
- [1]刘莉丽,孙永昌,陈颖,等.香烟烟雾提取物对CD4+T细胞向Th17细胞和调节性T细胞分化的影响[J].2014,(7).
- [2]龙颖姣,陈燕,陈平.慢性阻塞性肺疾病动物模型构建及评价[J].2014,(17).
- [3]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2013年修订版）[J].2013,(4).
- [4]Waterston, Robert H.,Lindblad-Toh, Kerstin,Birney, Ewan,etc.Initial sequencing and comparative analysis of the mouse genome.[J].2002,420(6915).
- [5]Owen CA.Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.[J].2005,2(4).
- [6]Verheijden KA,Kraneveld AD,Braber S,etc.A comparison of fixation methods on lung morphology in a murine model of emphysema.[J].2010,299(6 Pt.1).
- [7]Braber,S.,Kerstjens,H.A.M.,Bezemer,G.F.G.,etc.An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease[J].2012,185(8).
- [8]Charles G, Irvin,Jason H T, Bates.Measuring the lung function in the mouse: the challenge of size.[J].2003,4.
- [9]D, Morrison,R M, Strieter,S C, Donnelly,etc.Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers.[J].1998,12.
- [10]David A, Groneberg,K Fan, Chung.Models of chronic obstructive pulmonary disease.[J].2004,5.
- [11]K F, Chung,I M, Adcock.Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.[J].2008,31(6).
- [12]Kubo K,Droma Y,Hanaoka M,etc.Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats.[J].2010,35(4).
- [13]Yan Chen,Hanaoka, Masayuki,Ping Chen,etc.Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema.[J].2009,40(4).
- [14]Churg A,Cosio M,Wright JL.Mechanisms of cigarette smoke-induced COPD: insights from animal models.[J].2008,294(4 Pt.1).
- [15]Maike, Leberl,Adelheid, Kratzer,Laimute, Taraseviciene-Stewart.Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page?[J].2013,4.
- [16]Thomas L, Croxton,Gail G, Weinmann,Robert M, Senior,etc.Future research directions in chronic obstructive pulmonary disease.[J].2002,165(6).
- [17]S, Lim,N, Roche,B G, Oliver,etc.Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10.[J].2000,162.
- [18]P J, Barnes,S D, Shapiro,R A, Pauwels.Chronic obstructive pulmonary disease: molecular and cellular mechanisms.[J].2003,22(4).
- [19]Choe KH,Scerbavicius R,Fontenot AP,etc.An animal model of autoimmune emphysema.[J].2005,171(7).
- [20]R T, Abboud,S, Vimalanathan.Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.[J].2008,12(4).
- [21]Jigme M. Sethi,Carolyn L. Rochester.Smoking and Chronic Obstructive Pulmonary Disease[J].2000,21(1).
- [22]A, Churg,S, Zhou,J L, Wright.Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD.[J].2012,39(1).
- [23]Pauwels RA,Joos GF,Brusselle GG,etc.Murine models of COPD.[J].2006,19(3).
- [24]Taraseviciene-Stewart L,Scerbavicius R,Gera L,etc.Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats.[J].2003,167(11).
- [25]V M, Keatings,P D, Collins,D M, Scott,etc.Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.[J].1996,153(2).
- [26]C, Fletcher,R, Peto.The natural history of chronic airflow obstruction.[J].1977,1(6077).
- [27]Jonasson S,Hedenstrom H,Hjoberg J,etc.Comparisons of effects of intravenous and inhaled methacholine on airway physiology in a murine asthma model.[J].2009,165(2).
- [28]Carrozzi L,Viegi G,Baldacci S,etc.Epidemiology of chronic obstructive pulmonary disease (COPD).[J].2001,68(1).
- [29]De Vooght,Rinaldi M,Vanoirbeek JA.Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases.[J].2010,42(1).
- [30]Chen,P.,Luo,H.,Wu,S.-J.,etc.Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice[J].2013,39(1).
- [31]H R, Wirtz,M, Schmidt.Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture.[J].1996,9(1).